Agenda - Extraordinary Management Board meeting: 28 April 2025
Submitted by Anonymous (not verified) on 28 April 2025 - 11:40
Agenda - Extraordinary Management Board meeting: 28 April 2025
Agenda - Extraordinary Management Board meeting: 28 April 2025
Human medicines European public assessment report (EPAR): Twynsta, telmisartan,amlodipine, Date of authorisation: 07/10/2010, Revision: 15, Status: Authorised
Measles
EudraVigilance Expert Working Group (EV-EWG) work programme 2025-2026
Summary of opinion: Xofluza, 25/04/2025 Positive
Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised
Summary of opinion: Amvuttra, 25/04/2025 Positive
Summary of opinion: Veklury, 25/04/2025 Positive
Summary of opinion: Calquence, 25/04/2025 Positive
Summary of opinion: Vyvgart, 25/04/2025 Positive